<DOC>
	<DOC>NCT00632385</DOC>
	<brief_summary>To assess the efficacy and safety of eletriptan for migraine headaches in subjects who were not satisfied with rizatriptan therapy</brief_summary>
	<brief_title>Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Eletriptan</mesh_term>
	<mesh_term>Rizatriptan</mesh_term>
	<criteria>Diagnosis of migraine headache according to International Headache Society criteria and migraine headaches for at least 1 year Eletriptan naive Previously treated with rizatriptan and failed to achieve a satisfactory response within the past 12 months Nonmigraine headaches on average more than 6 days per month or have less than 24 hours of freedom from headache between migraine attacks Migraine attacks that are atypical or chronic daily headaches A history of migraine with prolonged aura, familial hemiplegic migraine, basilar migraine, migrainous infarction, migraine aura without headache, migraine with acute onset aura</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>